产品名称
PRONOVA® SLG 20, sodium alginate solution, Mw 75-150 kDa, guluronate monomer units ≥60 %
sterility
sterile (Total viable count (CFU/g))
form
powder
mol wt
Mw 75-150 kDa
composition
guluronate monomer units, ≥60%
G/M ratio, ≥1.5
pH
5.5-8.5 (20 °C, 1% in water)
viscosity
20-99 mPa.s, 1 % in water(20 °C)
Quality Level
Application
Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.
Disclaimer
NOT FOR USE IN HUMANS
General description
SLG-20 is made from an alginate where over 60% of the monomer units are guluronate and is a highly purified and well-characterized sodium alginate. The molecular weight for PRONOVA SLG-20 is in the 75000 – 220000 g/mol range. The ultra low levels of endotoxins, proteins and product sterility allows for a big variety of in vitro and in vivo applications.
Legal Information
Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.
wgk
WGK 1
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持